Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Cited In for PubMed (Select 20812290)

1.

Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy.

Walia S, Acharya A.

Beilstein J Nanotechnol. 2015 Feb 24;6:546-58. doi: 10.3762/bjnano.6.57. eCollection 2015. Review.

2.

Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.

Kaittanis C, Shaffer TM, Thorek DL, Grimm J.

Crit Rev Oncog. 2014;19(3-4):143-76. Review.

3.

Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging.

Xue S, Wang Y, Wang M, Zhang L, Du X, Gu H, Zhang C.

Int J Nanomedicine. 2014 May 21;9:2527-38. doi: 10.2147/IJN.S59754. eCollection 2014.

4.

Nanoparticle contrast agents for computed tomography: a focus on micelles.

Cormode DP, Naha PC, Fayad ZA.

Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):37-52. doi: 10.1002/cmmi.1551. Review.

5.

Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.

Allijn IE, Leong W, Tang J, Gianella A, Mieszawska AJ, Fay F, Ma G, Russell S, Callo CB, Gordon RE, Korkmaz E, Post JA, Zhao Y, Gerritsen HC, Thran A, Proksa R, Daerr H, Storm G, Fuster V, Fisher EA, Fayad ZA, Mulder WJ, Cormode DP.

ACS Nano. 2013 Nov 26;7(11):9761-70. doi: 10.1021/nn403258w. Epub 2013 Oct 17.

6.

Surface functionalization of gold nanoparticles with red blood cell membranes.

Gao W, Hu CM, Fang RH, Luk BT, Su J, Zhang L.

Adv Mater. 2013 Jul 12;25(26):3549-53. doi: 10.1002/adma.201300638. Epub 2013 May 27.

7.

Multifunctional gold nanoparticles for diagnosis and therapy of disease.

Mieszawska AJ, Mulder WJ, Fayad ZA, Cormode DP.

Mol Pharm. 2013 Mar 4;10(3):831-47. doi: 10.1021/mp3005885. Epub 2013 Feb 11. Review.

8.

Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.

Cormode DP, Sanchez-Gaytan BL, Mieszawska AJ, Fayad ZA, Mulder WJ.

NMR Biomed. 2013 Jul;26(7):766-80. doi: 10.1002/nbm.2909. Epub 2013 Jan 10. Review.

9.

X-ray-computed tomography contrast agents.

Lusic H, Grinstaff MW.

Chem Rev. 2013 Mar 13;113(3):1641-66. doi: 10.1021/cr200358s. Epub 2012 Dec 5. Review. No abstract available.

10.

Multimodal iron oxide nanoparticles for hybrid biomedical imaging.

Heidt T, Nahrendorf M.

NMR Biomed. 2013 Jul;26(7):756-65. doi: 10.1002/nbm.2872. Epub 2012 Oct 15. Review.

11.

Letter to the editor re: spectral Hounsfield units--a new radiological concept.

Cormode DP, Fayad ZA.

Eur Radiol. 2013 Mar;23(3):640-1. doi: 10.1007/s00330-012-2645-5. Epub 2012 Sep 13. No abstract available.

12.

Nanoparticles and their potential for application in bone.

Tautzenberger A, Kovtun A, Ignatius A.

Int J Nanomedicine. 2012;7:4545-57. doi: 10.2147/IJN.S34127. Epub 2012 Aug 17. Review.

13.

Personalized nanomedicine advancements for stem cell tracking.

Janowski M, Bulte JW, Walczak P.

Adv Drug Deliv Rev. 2012 Oct;64(13):1488-507. doi: 10.1016/j.addr.2012.07.008. Epub 2012 Jul 20. Review.

14.

Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications.

De M, Chou SS, Joshi HM, Dravid VP.

Adv Drug Deliv Rev. 2011 Nov;63(14-15):1282-99. doi: 10.1016/j.addr.2011.07.001. Epub 2011 Aug 6.

15.

Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.

Kievit FM, Zhang M.

Adv Mater. 2011 Sep 22;23(36):H217-47. doi: 10.1002/adma.201102313. Epub 2011 Aug 15. Review.

16.

Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.

Ferris DP, Lu J, Gothard C, Yanes R, Thomas CR, Olsen JC, Stoddart JF, Tamanoi F, Zink JI.

Small. 2011 Jul 4;7(13):1816-26. doi: 10.1002/smll.201002300. Epub 2011 May 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk